From the national system of technological innovation to the “New Projectment Economy” in China by ELIAS JABBOUR, UALLACE MOREIRA

Get full text

Political Economy of the Coup d’État in Brazil by Alexis Dantas, Elias Jabbour

Get full text

Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies by Elias Jabbour, Hagop Kantarjian

Get full text

A “NOVA ECONOMIA DO PROJETAMENTO” NO COMBATE À COVID-19 E AS CAPACIDADES ESTATAIS CHINESAS COMO FORÇA POLÍTICA ESTRATÉGICA by Elias Jabbour, Bernardo Salgado Rodrigues

Get full text

BCL2 inhibition in adult acute lymphoblastic leukemia: ready for primetime? by Nitin Jain, Elias Jabbour, Marina Konopleva

Get full text

“O caminho chinês”: desenvolvimento desigual, projetamento e socialismo by Elias Jabbour, Vítor Boa Nova, Javier Vadell

Get full text

On The Chinese Socialist Market Economy And The “New Projectment Economy” by Elias Jabbour, Alexis Dantas, Carlos José Espíndola

Get full text

Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies by Elias Jabbour, Oliver G. Ottmann, Michael Deininger, Andreas Hochhaus

Get full text

Mutant BCR-ABL clones in chronic myeloid leukemia by Michael S. Mathisen, Hagop M. Kantarjian, Jorge Cortes, Elias Jabbour

Get full text

Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directions by Nicholas J. Short, Elias Jabbour, Nitin Jain, Hagop Kantarjian

Get full text

Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor by David Sanford, Hagop Kantarjian, Jeffrey Skinner, Elias Jabbour, Jorge Cortes

Get full text

South Korea’s and China’s catching-up: a new-developmentalist analysis by LUIZ CARLOS BRESSER-PEREIRA, ELIAS JABBOUR, LUIZ FERNANDO DE PAULA

Get full text

Unexpected Mediastinal Mass Etiology in B-Acute Lymphoblastic Leukemia by Luan Phan, Elias Jabbour, Mara B. Antonoff, Nitin Jain, Pei Lin, Cesar Moran, Naveen Pemmaraju

Get full text

The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades by Elias Jabbour, Nicholas J. Short, Nitin Jain, Fadi G. Haddad, Mary Alma Welch, Farhad Ravandi, Hagop Kantarjian

Get full text

Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia by Aram Bidikian, Hagop Kantarjian, Elias Jabbour, Nicholas J. Short, Keyur Patel, Farhad Ravandi, Koji Sasaki, Ghayas C. Issa

Get full text

Management of chronic myeloid leukemia in 2023 – common ground and common sense by Jayastu Senapati, Koji Sasaki, Ghayas C. Issa, Jeffrey H. Lipton, Jerald P. Radich, Elias Jabbour, Hagop M. Kantarjian

Get full text

P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA by Aram Bidikian, Nicholas Short, Ramya Ganesh, Allison Pike, Koji Sasaki, Elias Jabbour, Michael Andreeff, Jorge Cortes, Ghayas Issa

Get full text

Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy by Alfonso Quintás-Cardama, Hagop Kantarjian, Susan O’Brien, Elias Jabbour, Gautam Borthakur, Farhad Ravandi, Srdan Verstovsek, Jianqin Shan, Jorge Cortes

Get full text

An Unsuspected Finding of t(9;22): A Rare Case of Philadelphia Chromosome-Positive B-Lymphoblastic Lymphoma by Prajwal Boddu, C. Cameron Yin, Rashmi Kanagal-Shamanna, Guillin Tang, Beenu Thakral, Tapan Kadia, Marina Konopleva, Elias Jabbour, Nitin Jain

Get full text

Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy by Naveen Pemmaraju, Hagop Kantarjian, Jianqin Shan, Elias Jabbour, Alfonso Quintas-Cardama, Srdan Verstovsek, Farhad Ravandi, William Wierda, Susan O’Brien, Jorge Cortes

Get full text